Dosage Forms

Articles

The companies will receive upfront funding from the European Union for the scale-up of manufacturing capabilities at industrial sites in Belgium, Italy, Germany, and France.



Sanofi and GSK to Provide the EU with 300 Million Doses of its COVID-19 Vaccine Candidate

The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.

Russia Completes Deals with India, Mexico, and Brazil for Sputnik V

BioNTech plans to produce up to 250 million doses of its COVID-19 vaccine candidate, BNT162b2, in the first half of 2021.

BioNTech to Acquire Novartis GMP Facility for COVID-19 Vaccine Production

Valneva will supply the UK government with an initial 60 million doses of the vaccine in the second half of 2021, if successful, and will provide more doses thereafter. 

Valneva Enters into $1.6-Billion Partnership with UK Government for COVID-19 Vaccine

Jennifer Markarian is a contributing editor for 

Polymeric containers offer an alternative to glass.

Considering Materials for Vaccine Containers

The funding will help advance the vaccine’s clinical evaluation, potential marketing authorization, development and manufacturing in Germany, and the number of participants in late-stage clinical trials.

BioNTech to Receive Funding from BMBF for its COVID-19 Vaccine Program

Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.

AZD1222 Clinical Trials Resume in the UK

AMRI will provide AstraZeneca with manufacturing capacity and sterile fill/finish services at its drug product manufacturing facility in Albuquerque, NM. 

AMRI Signs Agreement with AstraZeneca for COVID-19 Vaccine Delivery

The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.

AstraZeneca Pauses Clinical Trial on COVID-19 Vaccine for Safety Review

As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.

Vaccines